TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) Director Thomas Gunderson sold 9,624 shares of TransMedics Group stock in a transaction on Monday, June 15th. The shares were sold at an average price of $75.06, for a total transaction of $722,377.44. Following the completion of the sale, the director directly owned 16,642 shares of the […]

Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky acquired 8,435 shares of Parabilis Medicines stock in a transaction on Friday, June 12th. The stock was acquired at an average price of $27.67 per share, with a total value of $233,396.45. Following the purchase, the director directly owned 20,935 shares in the company, […]